Lab Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Allegiance Equity Corporation
Allegiance Equity Corporation announces collaboration with Canadian Dairy Commission and Guelph Food Technologies Corporation for Alzheimers and Dementia formulation GG-XT
July 13th, 2008
The Canadian Dairy Commission has funded the formulation of two dairy beverages with GG-XT for Allegiance at Guelph Food Technologies. Allegiance filed Canadian and International Patent Applications, and Health Canada Natural Product Applications for GG-XT. GG-XT is a proprietary compound of Panax Gensing and Gingko Giloba for the treatment and prevention of Alzheimers and Dementia. GG-XT improves memory, cognitive function, vitality of life and mental well-being. Keywords: Allegiance Equity Corporation, Dementia, Central Nervous System Disease, Alzheimer Disease, Patents Actions, Marketing and Licensing Agreements, Regulatory Actions,...
Source: Lab Business Week (2008-07-13)
|
